Former FDA Chief Scientist Jesse L. Goodman, MD, MPH, provides insights on the potential consequences of these new recommendations.
Jesse L. Goodman, MD, MPH
Advertisement
Goodman is director of Center on Medical Product Access, Safety and Stewardship (COMPASS) Georgetown University, and a former FDA chief scientist.
Articles by Jesse L. Goodman, MD, MPH
Advertisement
Latest Updated Articles
How Should We Interpret the Changes to the Childhood Vaccine Schedule?Published: January 6th 2026 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Measles Update: February 6, 2026
2
Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus
3
HIV in the Black Community: Shifting from Stigma and Health Inequalities to Communication and Care Initiatives
4
Antibiotics Deconstructed: IV Fosfomycin
5